R

Rightangled

Personalized medicine via at-home tests, prescriptions

Partnership Executive - Pharma

Full-Time
No salary listed
Mid
London, UK
In Person
Sales & Account ManagementBusiness Development & Partnerships

About the job

Requirements
  • At least 3 years of experience in business development, partnerships, or sales within the pharmaceutical, life sciences, or healthcare services industry.
  • Strong understanding of pharmaceutical regulatory and market access environments, including UK bodies such as the MHRA and GPhC, healthcare and procurement frameworks such as the NHS, UAE regulatory authorities (e.g. MOHAP, DHA, DOH), and regional distribution models.
  • Proven ability to navigate multi-market, cross-border partnership structures and build trust with stakeholders operating under different regulatory systems.
  • Ability to support and coordinate government and public affairs activities.
  • Willingness to travel as needed for partner meetings and industry events.
Responsibilities
  • Manage and grow relationships with existing partners and clinics, ensuring satisfaction, retention, and expanded engagement.
  • Identify, approach, and convert new clients, partners, and business leads within the pharmaceutical and healthcare sector.
  • Develop and execute partnership strategies aligned with company growth targets.
  • Represent the company at industry events, conferences, and meetings to build a professional network.
  • Contribute to pharmaceutical industry associations and build alliances that communicate the company's positions and messages.
  • Track the pipeline, partnership performance, and market opportunities, and report regularly to leadership.
  • Collaborate with regulatory, operations, and technical teams to ensure smooth partner onboarding and delivery.
  • Stay current on pharmaceutical market trends, regulatory changes, and the competitive landscape across multiple markets.

About the company

Rightangled provides personalized medicine through at-home health and DNA testing paired with online prescription delivery. It offers DNA tests for wellness, fitness, and nutrition, and an online pharmacy that dispenses medications after a clinician-guided online consultation. Tests and prescriptions are delivered to patients’ doors, supported by telehealth-style consultations. The company differentiates itself by integrating genetic testing directly with prescription delivery and digital care, backed by regulatory compliance (CQC and GPhC) and partnerships (Sibie Group, Wegoss Online Pharmacy). Its goal is to make genetic information actionable in everyday medical care, using digital tools to tailor treatments to each person’s genetic makeup.

Company Size

11-50

Company Stage

Seed

Total Funding

$1.7M

Headquarters

London, United Kingdom

Founded

2015

Get referred to Rightangled

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Companies House shows Rightangled active in July 2026 with 2025 accounts due September.
  • June 2026 oral Wegovy approval expands a high-margin category Rightangled already markets.
  • Rightangled's 2026 content and Medetone links show active acquisition and dispensing infrastructure.

What critics are saying

  • Reuters reported October 2023 Ozempic marketing against UK guidance, proving regulatory slippage.
  • Boots, Morrisons, and Superdrug can commoditize oral semaglutide pricing by summer 2026.
  • If CQC or GPhC enforcement tightens, prescription revenue collapses immediately.

What makes Rightangled unique

  • Rightangled blends DNA testing, clinician consultations, and prescription dispensing under one funnel.
  • Sibie Group control links Rightangled with Medetone dispensing, tightening fulfillment and compliance.
  • Its 2026 Wegovy-pill coverage signals early positioning in personalized obesity treatment.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Employee Discounts on Healthcare Products
  • Professional Development Budget

Growth & Insights

6 month growth

-6%

1 year growth

0%

2 year growth

-6%